Clinical Trial Update: Voriconazole as Prophylaxis for Liver Transplant Recipients

View source ↗

Summary

This update notes the completed status of a clinical trial evaluating voriconazole as prophylaxis for fungal infections in liver transplant recipients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fungemia
• Mycosis

Drugs mentioned

• VORICONAZOLE (Voriconazole)

Snippet

Sponsor: University of Pittsburgh | Conditions: Fungemia, Mycoses | Status: COMPLETED